As of 2025-10-18, the EV/EBITDA ratio of Bolt Biotherapeutics Inc (BOLT) is -0.03. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BOLT's latest enterprise value is 1.44 mil USD. BOLT's TTM EBITDA according to its financial statements is -51.75 mil USD. Dividing these 2 quantities gives us the above BOLT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.8x - 15.2x | 13.4x |
| Forward P/E multiples | 15.4x - 36.2x | 20.4x |
| Fair Price | (410.64) - (404.71) | (450.53) |
| Upside | -7240.6% - -7137.5% | -7934.3% |
| Date | EV/EBITDA |